DK484785A - Bromcryptinholdige oejendraaber - Google Patents

Bromcryptinholdige oejendraaber Download PDF

Info

Publication number
DK484785A
DK484785A DK484785A DK484785A DK484785A DK 484785 A DK484785 A DK 484785A DK 484785 A DK484785 A DK 484785A DK 484785 A DK484785 A DK 484785A DK 484785 A DK484785 A DK 484785A
Authority
DK
Denmark
Prior art keywords
bromcrypt
contents
bromcrypt contents
Prior art date
Application number
DK484785A
Other languages
Danish (da)
English (en)
Other versions
DK484785D0 (da
Inventor
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK484785D0 publication Critical patent/DK484785D0/da
Publication of DK484785A publication Critical patent/DK484785A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK484785A 1984-10-24 1985-10-22 Bromcryptinholdige oejendraaber DK484785A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426922A GB8426922D0 (en) 1984-10-24 1984-10-24 Galenic formulation

Publications (2)

Publication Number Publication Date
DK484785D0 DK484785D0 (da) 1985-10-22
DK484785A true DK484785A (da) 1986-04-25

Family

ID=10568697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484785A DK484785A (da) 1984-10-24 1985-10-22 Bromcryptinholdige oejendraaber

Country Status (15)

Country Link
US (1) US4654345A (en, 2012)
JP (1) JPS61103825A (en, 2012)
AU (1) AU4892885A (en, 2012)
BE (1) BE903483A (en, 2012)
DE (1) DE3536560A1 (en, 2012)
DK (1) DK484785A (en, 2012)
FR (1) FR2571962A1 (en, 2012)
GB (2) GB8426922D0 (en, 2012)
GR (1) GR852545B (en, 2012)
IL (1) IL76781A0 (en, 2012)
IT (1) IT1237360B (en, 2012)
NL (1) NL8502805A (en, 2012)
PT (1) PT81352B (en, 2012)
SE (1) SE8504976L (en, 2012)
ZA (1) ZA858184B (en, 2012)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
WO1996011672A1 (en) * 1994-10-13 1996-04-25 Wakamoto Pharmaceutical Co., Ltd. Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US20070275955A1 (en) * 1997-07-31 2007-11-29 Ed. Geistlich Soehne Ag Method of treating tumors
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US6821968B2 (en) 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
PL3445362T3 (pl) 2016-04-20 2022-05-30 Veroscience Llc Kompozycja i sposób leczenia zaburzeń metabolicznych
ES2991048T3 (es) 2017-10-18 2024-12-02 Veroscience Llc Formulaciones mejoradas de bromocriptina
PL430675A1 (pl) * 2019-07-23 2021-01-25 Osęka Maciej Bromokryptyna do zastosowania w leczeniu chorób oczu związanych z podwyższonym poziomem śródbłonkowego czynnika wzrostu naczyń (VEGF) oraz kompozycja farmaceutyczna zawierająca bromokryptynę
EP4034128A4 (en) 2019-09-23 2024-02-07 VeroScience LLC TUMOR REGRESSION INDUCTION METHOD

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (en, 2012) * 1973-05-17 1981-09-03
CH601321A5 (en, 2012) * 1975-01-06 1978-07-14 Sandoz Ag
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU40533B (en) * 1978-09-04 1986-02-28 Lek Tovarna Farmacevtskih Process for preparing 2-bromoergosinine
FI793888A7 (fi) * 1978-12-21 1981-01-01 Sandoz Ag Galeenisia seoksia.
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
CA1141663A (en) * 1979-09-06 1983-02-22 Yukihisa Ishii Ophthalmic solution for intraocular pressure adjustment
GB2058746A (en) * 1979-09-20 1981-04-15 Erba Farmitalia 6,7-Secoergolines
DE3033898A1 (de) * 1980-09-09 1982-04-22 Dr. Thilo & Co GmbH, 8021 Sauerlach Arzneimittel zur lokalen behandlung des glaukoms
BE890369A (fr) * 1980-09-18 1982-03-16 Sandoz Sa Nouveaux medicaments a base d'inhibiteurs de la secretion de la prolactine pour le traitement de l'arteriosclerose
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma

Also Published As

Publication number Publication date
JPS61103825A (ja) 1986-05-22
IT8548703A0 (it) 1985-10-23
SE8504976L (sv) 1986-04-25
NL8502805A (nl) 1986-05-16
IT1237360B (it) 1993-05-31
GR852545B (en, 2012) 1986-02-18
AU4892885A (en) 1986-07-17
US4654345A (en) 1987-03-31
SE8504976D0 (sv) 1985-10-22
DK484785D0 (da) 1985-10-22
ZA858184B (en) 1987-06-24
DE3536560A1 (de) 1986-04-24
PT81352B (en) 1987-08-05
BE903483A (fr) 1986-04-21
GB2165752A (en) 1986-04-23
GB8525947D0 (en) 1985-11-27
IL76781A0 (en) 1986-02-28
FR2571962A1 (fr) 1986-04-25
PT81352A (en) 1985-11-01
GB8426922D0 (en) 1984-11-28

Similar Documents

Publication Publication Date Title
DK28892A (da) Quinolin-forbindelser
FI840297A0 (fi) Mellanbotten foer rullvagn
DK484785D0 (da) Bromcryptinholdige oejendraaber
DK159245C (da) Dentalsut
DK346285D0 (da) Toermursystem
ATA98284A (de) Schalplatte
DK446085D0 (da) Triazol- eller imidazolfungicidholdige materialer
FI840466A0 (fi) Lyftkil
DK1985A (da) Bremse-spaerreventil
DK164504C (da) Beta-methylen-thiophenethanaminer
DK78385D0 (da) Diazepinoindoler
KR860004473U (ko) 차 제조용 용기
DK207585A (da) Azolylvinylethere
FR2574373B1 (fr) Conteneur
FI840792A0 (fi) Inblaosbar vaermeisolering
FI840298A0 (fi) Naetsticka
ES283212Y (es) Envase
ES276911Y (es) Envase
ES277724Y (es) Envase
ES277521Y (es) Envase
SE8402901D0 (sv) Container
BR8406170A (pt) Container
DK257284D0 (da) Container
PT7617U (pt) Recipiente
BR8401923A (pt) Aperfeicoamento em container

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment